These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3958490

  • 21. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
    Candiani C, Franceschi A, Chignola R, Pasti M, Anselmi C, Benoni G, Tridente G, Colombatti M.
    Cancer Res; 1992 Feb 01; 52(3):623-30. PubMed ID: 1732050
    [Abstract] [Full Text] [Related]

  • 22. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
    Tonevitskiĭ AG, Zhukova OS, Rakhmanova VA, Arsen'eva EL, Bogacheva GT.
    Mol Biol (Mosk); 1988 Feb 01; 22(4):911-6. PubMed ID: 3141780
    [Abstract] [Full Text] [Related]

  • 23. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
    Manske JM, Buchsbaum DJ, Vallera DA.
    J Immunol; 1989 Mar 01; 142(5):1755-66. PubMed ID: 2465347
    [Abstract] [Full Text] [Related]

  • 24. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL, Li JL, Vitetta ES.
    J Immunol; 1994 Mar 01; 152(5):2368-76. PubMed ID: 8133047
    [Abstract] [Full Text] [Related]

  • 25. Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.
    Blakey DC, Watson GJ, Knowles PP, Thorpe PE.
    Cancer Res; 1987 Feb 15; 47(4):947-52. PubMed ID: 3492271
    [Abstract] [Full Text] [Related]

  • 26. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M, Johnson VG, Skopicki HA, Fendley B, Lewis MS, Youle RJ.
    J Immunol; 1987 May 15; 138(10):3339-44. PubMed ID: 2437188
    [Abstract] [Full Text] [Related]

  • 27. T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
    Casellas P, Ravel S, Bourrié BJ, Derocq JM, Jansen FK, Laurent G, Gros P.
    Blood; 1988 Oct 15; 72(4):1197-202. PubMed ID: 3262384
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
    Casellas P, Bourrie BJ, Gros P, Jansen FK.
    J Biol Chem; 1984 Aug 10; 259(15):9359-64. PubMed ID: 6746651
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
    Tonevitskiĭ AG.
    Mol Biol (Mosk); 1985 Aug 10; 19(4):1034-41. PubMed ID: 4047033
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
    Engert A, Burrows F, Jung W, Tazzari PL, Stein H, Pfreundschuh M, Diehl V, Thorpe P.
    Cancer Res; 1990 Jan 01; 50(1):84-8. PubMed ID: 2152774
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ.
    Cancer Res; 1989 Nov 01; 49(21):6153-60. PubMed ID: 2790828
    [Abstract] [Full Text] [Related]

  • 36. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G, Runge W, Jansen FK, Vallera DA.
    Cancer Res; 1985 Mar 01; 45(3):1328-36. PubMed ID: 3971376
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Jan 01; 44(1):201-8. PubMed ID: 6140077
    [Abstract] [Full Text] [Related]

  • 38. Effect of immunotoxins against Trypanosoma cruzi.
    Santana JM, Teixeira AR.
    Am J Trop Med Hyg; 1989 Aug 01; 41(2):177-82. PubMed ID: 2505622
    [Abstract] [Full Text] [Related]

  • 39. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC.
    Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
    Griffin TW, Childs LR, FitzGerald DJ, Levin LV.
    J Natl Cancer Inst; 1987 Oct 01; 79(4):679-85. PubMed ID: 3498854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.